メラノーマにおける免疫療法

Yan Xing¹, Helena T Wu^2,3, Swapnil Rajurkar³

¹City of Hope Comprehensive Cancer Center, Duarte, CA, USA. yxing@coh.org.

Cancer treatment and research

|August 23, 2025

まとめ

免疫療法や標的治療を含む皮膚性メラノーマの全身治療は,ネオアジュバント,アジュバント,ステージIVでの生存率を改善します. 治療の選択は,疾患の段階とBRAF変異の状態によって導かれます.

科学分野:

腫瘍学
皮膚科
免疫療法

背景:

皮膚性メラノーマの治療は,全身療法によって著しく進化した.
病気の異なる段階における最適な戦略を理解することは患者の治療結果にとって極めて重要です

研究の目的:

皮膚メラノーマの現在の全身治療戦略をレビューする.
ネオアジュバント,アジュバント,ステージIVの治療方法について議論する.
有効性,毒性,そして新興治療法を強調するために

主な方法:

皮膚メラノーマの全身治療の見直し
ネオアジュバント,アジュバント,および転移の設定における治療法の分析.
免疫チェックポイント阻害剤と標的療法に関するデータを含める.

主要な成果:

ニボルマブとイピリムマブによる新補助療法は高い応答率を示しています.
補助免疫療法と標的療法により,高リスクのメラノーマでは再発のない生存率が改善されます.
ステージIVの治療は,BRAF状態に基づいて免疫療法とMAPK経路阻害剤を使用します.

結論:

皮膚性メラノーマでは,全身療法は生存率と治療なしの間隔を著しく改善します.
治療の選択は,疾患のステージと分子マーカーに基づいて個別化されます.
腫瘍に浸透するリンパ球のような新興治療法が将来の治療の道を示しています

キーワード:

補助剤 BRAF変異ダブラフェニブ免疫療法イピリムマブメラノーマネオアジュバントニボルマブステージ4 メラノーマ標的型療法

さらに関連する動画

07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

1.1K

09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

14.8K

関連する概念動画

01:27

Tumor Immunotherapy

660

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

660

02:57

Targeted Cancer Therapies

7.8K

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

7.8K

01:30

Cancer Vaccines

509

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

509

02:50

Combination Therapies and Personalized Medicine

5.1K

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

5.1K

01:30

Skin Cancer

4.5K

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

4.5K

02:17

The Tumor Microenvironment

6.8K

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...